Vitamin D3, often called the “sunshine vitamin,” is well-known for its role in calcium homeostasis and bone health. But its influence goes far deeper. Over the past two decades, scientists have uncovered a compelling relationship between vitamin D3 levels and immune system regulation, particularly in the context of autoimmune diseases like multiple sclerosis (MS), type 1 diabetes, lupus, inflammatory bowel disease (IBD), and rheumatoid arthritis.

Vitamin D receptors (VDRs) are expressed on almost all immune cells, including T cells, B cells, and antigen-presenting cells, and vitamin D modulates both innate and adaptive immune responses [1,2]. Deficiency in this critical nutrient has been correlated with increased risk and severity of several autoimmune conditions [3–6].

Let’s take a closer look at how this powerful micronutrient works to keep the immune system balanced—and what happens when we don’t get enough.

How Vitamin D3 Regulates the Immune System

It’s easy to think of vitamins as background players in our health—important, sure, but maybe not all that dynamic. Vitamin D3 challenges that idea. Think of it as an immune system diplomat: it doesn’t shut down immune activity altogether, but it helps steer the immune response away from chronic, self-directed inflammation—the hallmark of autoimmune disease.

Vitamin D3 plays a powerful regulatory role in both innate immunity (your body’s first line of defense) and adaptive immunity (the system that learns and remembers threats). It does this by:

Promoting regulatory T cells (Tregs), which help prevent the immune system from attacking the body’s own tissues [7,8].

Inhibiting production of pro-inflammatory cytokines, such as IL-17 and interferon-gamma (IFN-γ), which are elevated in many autoimmune conditions [9,10].

Suppressing the activation and antigen-presenting capacity of dendritic cells, which helps reduce unnecessary immune activation [11].

This balance is crucial. In autoimmune diseases, the immune system becomes hyperactive and loses the ability to distinguish friend from foe. Vitamin D3’s immunomodulatory abilities help keep things in check, supporting an internal environment that’s less likely to trigger damaging immune responses.

Sunshine Shortfall: What Happens When D3 is Deficient?

It’s one thing to understand what vitamin D3 does in theory—but what about in the real world? What happens when we don’t get enough?

Unfortunately, vitamin D deficiency is incredibly common, especially in regions with long winters, people with darker skin tones, those who use sunscreen regularly (important for skin cancer prevention), and anyone who spends most of their time indoors. In fact, more than 40% of U.S. adults may be vitamin D deficient [12].

When vitamin D levels fall too low, the immune system can begin to spin out of control—becoming overly reactive and more prone to launching misguided attacks on healthy tissues [13-25]. For instance:

Multiple sclerosis (MS) is more common in populations living farther from the equator, where sunlight exposure—and thus vitamin D synthesis—is lower.

Type 1 diabetes has been linked to low D3 levels in infancy and early childhood, a critical time for immune programming.

Lupus patients often exhibit severe vitamin D deficiencies, and studies suggest low D3 levels are associated with greater disease activity and symptom severity].

And it’s not just about risk. Studies also suggest that maintaining optimal vitamin D levels may improve autoimmune disease management and reduce flare-ups.

Clinical Trials & Controversies

Can Supplementing Vitamin D3 Prevent or Treat Autoimmunity?

When it comes to nutrients and disease, the gold standard for proving benefit is the randomized controlled trial (RCT). So, how does vitamin D3 hold up under that kind of scientific scrutiny?

While not all studies have produced consistent results (science is rarely simple), several high-quality clinical trials and meta-analyses suggest that vitamin D3 may help reduce the risk or severity of certain autoimmune diseases.

For example:

In people with MS, vitamin D3 supplementation has been reported to reduce relapse rates and improve inflammation-related biomarkers [26,27].

Individuals with rheumatoid arthritis or IBD who received D3 often experienced improvements in disease symptoms and reduced inflammatory markers [28,29].

A 2022 analysis of the VITAL trial—a major RCT with over 25,000 participants—found that those who took 2,000 IU/day of vitamin D3 had a 22% lower incidence of autoimmune diseases after five years [30].

That said, results can vary based on genetics (like vitamin D receptor variants), baseline D3 levels, dosage, and duration of treatment [31–33]. So while vitamin D3 isn’t a cure-all, the evidence increasingly points to its value as a safe, low-cost intervention worth considering.

Now that we know the risks of deficiency, the next question is: how can we support healthy vitamin D levels—especially in ways that are sustainable and evidence-backed?

Here are the top strategies:

1. Safe Sun Exposure

The body produces vitamin D3 when your skin is exposed to UVB rays from the sun. Just 10–30 minutes of midday sun exposure a few times per week — without sunscreen — may help maintain healthy levels. But keep in mind: skin tone, latitude, season, and age all affect how much D you can make naturally, and too much sun increases skin cancer risk. So find a balance that works for you.

2. Eat Vitamin D–Rich Foods

Although it’s hard to get enough vitamin D through diet alone, certain foods can help:

Fatty fish like salmon and sardines

Egg yolks

Beef liver

UV-exposed mushrooms

Fortified foods, including plant-based milks, cereals, and orange juice

3. Supplement Wisely

If you’ve had your levels tested and are deficient — or if you live in an area with low sun — you might consider a high-quality D3 supplement.

General recommendations: 800–2,000 IU/day for maintenance

Therapeutic doses: Up to 5,000 IU/day, under medical supervision

Aim for a 25(OH)D blood level of 40–60 ng/mL, which appears optimal for immune regulation.

Pro tip: Look for supplements that use vitamin D3 rather than D2, as it’s more bioavailable and effective.

Autoimmune conditions can feel unpredictable—like your immune system is working against you. That’s why supporting immune balance is key, not just immune “boosting.” Tally Health’s Defend formula was designed with exactly that in mind. Defend by Tally Health includes Vitamin D3 in its potent, bioavailable form.

Whether you’re managing an autoimmune condition or just want to age with resilience, Defend is a science-backed ally you can trust.

Shop Defend

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. These products are intended only for healthy adults. If you are pregnant, nursing, taking any medications, or have any medical condition, consult your physician before use. Keep out of reach of children.

Citations

[1] Provvedini, D. M., Tsoukas, C. D., Deftos, L. J., & Manolagas, S. C. (1983). 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science, 221(4616), 1181–1183. https://doi.org/10.1126/science.6310748

[2] Bikle, D. (2020). Vitamin D: Newer concepts of its metabolism and function at the basic and clinical level. Frontiers in Endocrinology, 10, 678. https://doi.org/10.3389/fendo.2019.00678

[3] Arnson, Y., Amital, H., & Shoenfeld, Y. (2007). Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Annals of the Rheumatic Diseases, 66(9), 1137–1142. https://doi.org/10.1136/ard.2007.069831

[4] Agmon-Levin, N., Theodor, E., Segal, R. M., & Shoenfeld, Y. (2013). Vitamin D in systemic and organ-specific autoimmune diseases. Autoimmunity Reviews, 12(3), 349–357. https://doi.org/10.1016/j.autrev.2012.08.021

[5] Dankers, W., Colin, E. M., van Hamburg, J. P., & Lubberts, E. (2017). Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential. Journal of Immunology, 199(4), 1090–1098. https://doi.org/10.4049/jimmunol.1700265

[6] Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2015). Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA Neurology, 72(12), 1458–1465. https://doi.org/10.1001/jamaneurol.2015.1975

[7] Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., & O'Garra, A. (2002). In vitro generation of interleukin 10–producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1– and type 2–inducing cytokines. Nature Reviews Immunology, 2(7), 535–545. https://doi.org/10.1038/nri830

[8] Jeffery, L. E., Raza, K., Hewison, M. (2009). Vitamin D in rheumatoid arthritis—towards clinical application. Journal of Immunology, 183(10), 5458–5467. https://doi.org/10.4049/jimmunol.0803217

[9] Boonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F., & O'Garra, A. (2001). 1α,25-Dihydroxyvitamin D3 has a direct effect on naïve CD4+ T cells to enhance the development of Th2 cells. Journal of Immunology, 167(9), 4974–4980. https://doi.org/10.4049/jimmunol.167.9.4974

[10] Lemire, J. M., Archer, D. C., Beck, L., & Spiegelberg, H. L. (1985). Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. Journal of Clinical Investigation, 76(2), 759–766. https://doi.org/10.1172/JCI112028

[11] Penna, G., Amuchastegui, S., Giarratana, N., Daniel, K. C., Vulcano, M., Sozzani, S., & Adorini, L. (2005). 1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. Journal of Immunology, 174(1), 465–473. https://doi.org/10.4049/jimmunol.174.1.465

[12] Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357(3), 266–281. https://doi.org/10.1056/NEJMra070553

[13] Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S. M., Dyment, D. A., & Ebers, G. C. (2010). Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Medicine, 7(8), e1000348. https://doi.org/10.1371/journal.pmed.1000348

[14] Mohr, S. B., Garland, C. F., Gorham, E. D., & Garland, F. C. (2010). The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Preventive Medicine, 51(5), 228–233. https://doi.org/10.1016/j.ypmed.2010.07.007

[15] Kamen, D. L., & Tangpricha, V. (2010). Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. Current Opinion in Rheumatology, 22(4), 432–440. https://doi.org/10.1097/BOR.0b013e32833a4e17

[16] Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006). Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA, 296(23), 2832–2838. https://doi.org/10.1001/jama.296.23.2832

[17] Simpson, S., Jr., Taylor, B., Blizzard, L., Ponsonby, A. L., Pittas, F., Tremlett, H., & Dwyer, T. (2010). Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Multiple Sclerosis, 16(12), 1423–1431. https://doi.org/10.1177/1352458510383179

[18] Zipitis, C. S., & Akobeng, A. K. (2008). Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Archives of Disease in Childhood, 93(6), 512–517. https://doi.org/10.1136/adc.2007.128579

[19] Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M. R., & Virtanen, S. M. (2001). Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. The Lancet, 358(9292), 1500–1503. https://doi.org/10.1016/S0140-6736(01)06580-1

[20] Li, X., Liu, Y., Zheng, Y., Wang, P., Zhang, Y., & Ma, Y. (2018). Associations of serum 25(OH)D concentrations with autoimmune diseases: A systematic review and meta-analysis. Nutrients, 10(7), 908. https://doi.org/10.3390/nu10070908

[21] Toloza, S. M., Cole, D. E., Gladman, D. D., Ibanez, D., & Urowitz, M. B. (2010). Vitamin D insufficiency in a large female SLE cohort. Lupus, 19(7), 760–769. https://doi.org/10.1177/0961203309357768

[22] Schoindre, Y., Jallouli, M., Tanguy, M. L., Ghillani-Dalbin, P., Aumaître, O., & Frances, C. (2014). Vitamin D deficiency in systemic lupus erythematosus: association with disease activity and damage indices. Lupus Science & Medicine, 1(1), e000027. https://doi.org/10.1136/lupus-2014-000027

[23] Ruiz-Irastorza, G., Gordo, S., Olivares, N., Egurbide, M. V., & Aguirre, C. (2008). Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Rheumatology, 47(5), 602–606. https://doi.org/10.1093/rheumatology/ken016

[24] Cantorna, M. T. (2012). Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Archives of Biochemistry and Biophysics, 523(1), 103–111. https://doi.org/10.1016/j.abb.2012.03.002

[25] Smolders, J., Menheere, P., Kessels, A., Damoiseaux, J., Hupperts, R. (2008). Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Multiple Sclerosis, 14(9), 1220–1224. https://doi.org/10.1177/1352458508094399

[26] Soilu-Hänninen, M., Aivo, J., Lindström, B. M., Elovaara, I., Sumelahti, M. L., Färkkilä, M., & Atula, S. (2012). A randomised, double blind, placebo controlled trial with vitamin D3 as an add-on treatment to interferon β-1b in patients with multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 83(5), 565–571. https://doi.org/10.1136/jnnp-2011-301876

[27] Kampman, M. T., Steffensen, L. H., Mellgren, S. I., & Jørgensen, L. (2012). Effect of vitamin D3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Multiple Sclerosis, 18(8), 1144–1151. https://doi.org/10.1177/1352458511434607

[28] Gatenby, P. A., Lucas, R. M., & Swaminathan, A. (2013). Vitamin D deficiency and risk for rheumatic diseases: An update. Rheumatology International, 33(1), 178–182. https://doi.org/10.1007/s00296-011-2335-7

[29] Naderpoor, N., Mousa, A., Fernanda Gomez Arango, M., Barrett, H. L., Dekker Nitert, M., & de Courten, B. (2019). Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: A randomized placebo-controlled trial. Journal of Translational Medicine, 17(1), 110. https://doi.org/10.1186/s12967-019-1858-5

[30] Hahn, J., Cook, N. R., Alexander, L. M., et al. (2022). Vitamin D and marine omega-3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ, 376, e066452. https://doi.org/10.1136/bmj-2021-066452

[31] Antico, A., Tampoia, M., Tozzoli, R., Bizzaro, N. (2012). Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Clinical Rheumatology, 31(12), 1951–1955. https://doi.org/10.1007/s10067-012-2043-3

[32] Martineau, A. R., Jolliffe, D. A., Hooper, R. L., et al. (2017). Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of individual participant data. BMJ, 356, i6583. https://doi.org/10.1136/bmj.i6583

[33] Jolliffe, D. A., Camargo, C. A. Jr, Sluyter, J. D., et al. (2021). Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomized controlled trials. The Lancet Diabetes & Endocrinology, 9(5), 276–292. https://doi.org/10.1016/S2213-8587(21)00051-6

Save this email to start commenting

Save this email to start commenting